DK0964856T3 - Bicycliske aromatiske aminosyrer - Google Patents

Bicycliske aromatiske aminosyrer

Info

Publication number
DK0964856T3
DK0964856T3 DK98908063T DK98908063T DK0964856T3 DK 0964856 T3 DK0964856 T3 DK 0964856T3 DK 98908063 T DK98908063 T DK 98908063T DK 98908063 T DK98908063 T DK 98908063T DK 0964856 T3 DK0964856 T3 DK 0964856T3
Authority
DK
Denmark
Prior art keywords
amino acids
aromatic amino
bicyclic aromatic
bicyclic
acids
Prior art date
Application number
DK98908063T
Other languages
Danish (da)
English (en)
Inventor
Simon Goodman
Joachim Maerz
Peter Raddatz
Friedrich Rippmann
Matthias Wiesner
Beate Diefenbach
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Application granted granted Critical
Publication of DK0964856T3 publication Critical patent/DK0964856T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/281,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/341,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
    • C07D265/361,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings condensed with one six-membered ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D319/00Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/101,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/141,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
    • C07D319/161,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D319/201,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring with substituents attached to the hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Vascular Medicine (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK98908063T 1997-02-13 1998-02-06 Bicycliske aromatiske aminosyrer DK0964856T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19705450A DE19705450A1 (de) 1997-02-13 1997-02-13 Bicyclische aromatische Aminosäuren
PCT/EP1998/000636 WO1998035949A1 (de) 1997-02-13 1998-02-06 Bicyclische aromatische aminosäuren

Publications (1)

Publication Number Publication Date
DK0964856T3 true DK0964856T3 (da) 2003-02-10

Family

ID=7820093

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98908063T DK0964856T3 (da) 1997-02-13 1998-02-06 Bicycliske aromatiske aminosyrer

Country Status (25)

Country Link
EP (1) EP0964856B1 (no)
JP (1) JP4327257B2 (no)
KR (1) KR20000071030A (no)
CN (1) CN1085205C (no)
AR (1) AR010894A1 (no)
AT (1) ATE225776T1 (no)
AU (1) AU735313B2 (no)
BR (1) BR9807345A (no)
CA (1) CA2280727C (no)
CY (1) CY2341B1 (no)
CZ (1) CZ297366B6 (no)
DE (2) DE19705450A1 (no)
DK (1) DK0964856T3 (no)
ES (1) ES2183332T3 (no)
HU (1) HUP0001138A3 (no)
ID (1) ID22533A (no)
NO (1) NO313289B1 (no)
PL (1) PL335101A1 (no)
PT (1) PT964856E (no)
RU (1) RU2187506C2 (no)
SI (1) SI0964856T1 (no)
SK (1) SK284646B6 (no)
TR (1) TR199901962T2 (no)
WO (1) WO1998035949A1 (no)
ZA (1) ZA981178B (no)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040063790A1 (en) * 1996-05-31 2004-04-01 The Scripps Research Institute Methods for inhibition of angiogenesis
CN1140511C (zh) 1998-04-09 2004-03-03 明治制果株式会社 作为整合素αvβ3拮抗剂的氨基哌啶衍生物
KR20010108499A (ko) 1999-04-13 2001-12-07 스타르크, 카르크 인테그린 수용체 리간드
US6750219B1 (en) 1999-08-05 2004-06-15 Meiji Seika Kaisha, Ltd. Ω-amino-α-hydroxycarboxylic acid derivatives having integrin ανβ3 antagonistic activity
WO2001047874A1 (en) * 1999-12-24 2001-07-05 Smithkline Beecham P.L.C. (hetero)bicyclymethanesulfonylamino-substituted hydroxamic acid derivatives
US6617461B2 (en) * 2000-01-25 2003-09-09 Kaneka Corporation Process for preparation of optically active N-substituted azetidine-2-carboxylic acids
BR0115077A (pt) * 2000-11-01 2003-12-23 Merck Patent Ges Mit Beschroen Métodos e composições para o tratamento de doenças dos olhos
CN100384480C (zh) 2001-05-30 2008-04-30 斯克里普斯研究学院 核酸传递系统
BR0211604A (pt) * 2001-08-01 2004-08-24 Merck Patent Gmbh Inibidores de integrina para o tratamento de doenças do olho
WO2003068253A1 (en) * 2002-02-14 2003-08-21 Merck Patent Gmbh Methods and compositions for the treatment of eye diseases
DE10305784A1 (de) * 2003-02-12 2004-08-26 Merck Patent Gmbh Verfahren zur Herstellug bicyclischer aromatischer Aminosäuren sowie deren Zwischenprodukte
DE10337863A1 (de) 2003-08-18 2005-03-17 Merck Patent Gmbh Verwendung von Chromen-4-on-Derivaten
PT1765362E (pt) * 2004-06-04 2012-06-04 Scripps Research Inst Composições e métodos para o tratamento de doenças neovasculares
UA87854C2 (en) 2004-06-07 2009-08-25 Мерк Энд Ко., Инк. N-(2-benzyl)-2-phenylbutanamides as androgen receptor modulators
EP2380881B1 (en) * 2008-12-26 2017-01-25 Sumitomo Dainippon Pharma Co., Ltd. Novel bicyclic heterocyclic compound
WO2011024987A1 (ja) * 2009-08-31 2011-03-03 塩野義製薬株式会社 芳香族縮合へテロ環誘導体およびそれらを含有する医薬組成物
AR090259A1 (es) 2012-03-06 2014-10-29 Boehringer Ingelheim Int Inhibidores de benzodioxano de la produccion de leucotrieno para terapia de combinacion
WO2014014874A1 (en) 2012-07-17 2014-01-23 Boehringer Ingelheim International Gmbh Pyrazole derivatives which inhibit leukotriene production
JP2016523982A (ja) 2013-07-15 2016-08-12 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ロイコトリエン生成の阻害剤
JP6353899B2 (ja) 2013-07-15 2018-07-04 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ロイコトリエン生成の阻害剤
CA2950390C (en) 2014-05-30 2020-09-22 Pfizer Inc. Carbonitrile derivatives as selective androgen receptor modulators
WO2023275715A1 (en) 2021-06-30 2023-01-05 Pfizer Inc. Metabolites of selective androgen receptor modulators
AU2022376563A1 (en) 2021-11-01 2023-12-07 Alkahest, Inc. Benzodioxane modulators of leukotriene a4 hydrolase (lta4h) for prevention and treatment of aging-associated diseases

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5648368A (en) * 1992-12-01 1997-07-15 Merck & Co., Inc. Fibrinogen receptor antagonists
ES2186720T3 (es) * 1994-05-27 2003-05-16 Merck & Co Inc Composiciones para inhibir la reabsorcion osea mediada por osteoclastos.
DE19548709A1 (de) * 1995-12-23 1997-07-03 Merck Patent Gmbh Tyrosinderivate
DE19654483A1 (de) * 1996-06-28 1998-01-02 Merck Patent Gmbh Phenylalanin-Derivate
WO1998000395A1 (de) * 1996-06-28 1998-01-08 Merck Patent Gmbh Phenylalanin-derivate als integrin-inhibitoren

Also Published As

Publication number Publication date
RU2187506C2 (ru) 2002-08-20
AU735313B2 (en) 2001-07-05
WO1998035949A1 (de) 1998-08-20
CN1085205C (zh) 2002-05-22
TR199901962T2 (xx) 1999-12-21
HUP0001138A2 (hu) 2001-05-28
NO993901D0 (no) 1999-08-12
PT964856E (pt) 2003-02-28
EP0964856B1 (de) 2002-10-09
CA2280727A1 (en) 1998-08-20
HUP0001138A3 (en) 2002-10-28
NO313289B1 (no) 2002-09-09
BR9807345A (pt) 2000-03-21
DE19705450A1 (de) 1998-08-20
ATE225776T1 (de) 2002-10-15
SI0964856T1 (en) 2003-04-30
KR20000071030A (ko) 2000-11-25
NO993901L (no) 1999-10-12
ES2183332T3 (es) 2003-03-16
PL335101A1 (en) 2000-04-10
AR010894A1 (es) 2000-07-12
ID22533A (id) 1999-10-28
SK284646B6 (sk) 2005-08-04
ZA981178B (en) 1999-05-21
AU6620698A (en) 1998-09-08
SK107199A3 (en) 2000-05-16
CN1252064A (zh) 2000-05-03
DE59805895D1 (de) 2002-11-14
CA2280727C (en) 2008-05-06
JP2001511789A (ja) 2001-08-14
CZ287599A3 (cs) 1999-11-17
CY2341B1 (en) 2004-02-06
CZ297366B6 (cs) 2006-11-15
EP0964856A1 (de) 1999-12-22
JP4327257B2 (ja) 2009-09-09

Similar Documents

Publication Publication Date Title
DK0964856T3 (da) Bicycliske aromatiske aminosyrer
DK0877018T3 (da) Sulfonylaminocarboxylsyrer
NO20002990L (no) Nytt overflateprotein
NO2010013I2 (no) Rekombinant FSH-CTP
ATE292179T1 (de) Mehrfach substituierte proteasevarianten
NO985680D0 (no) Peptidderivater
NO980692D0 (no) Bryter
NO983849L (no) Peptidderivater
DE59804564D1 (de) Flachstrahler
DE59803277D1 (de) Schalter
DE59809916D1 (de) Flachstrahler
TR199701666A3 (tr) Sismanliga karsi proteinler
DE69813719D1 (de) Schalter
FR2759452B3 (fr) Fontaines pyro-aquatiques
FI973099A0 (fi) Installationsanordning hos balkongglasering
DE59806788D1 (de) Lauflichtanlage
DE69802830T2 (de) Aromatische substituierte naphtopyranen
DK1017798T3 (da) Lunasinpeptider
NO20000976D0 (no) Peptider
KR980004878U (ko) 회전식 광고 게시대
FI970511A0 (fi) Lutbart plan
FI3265U1 (fi) Liitäntäkeskus
DK0918991T3 (da) Assayfremgangsmåde